Alpha 2.0
Login Register
» Authors » F Rosen

F Rosen

Explore the profile of F Rosen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 122
Citations 1160
Followers 0
Related Specialties
Biochemistry
Oncology
General Medicine
Top 10 Co-Authors
R J MILHOLLAND
C A Nichol
M Mayer
N Kaiser
W A PERLZWEIG
H R Harding
M M Ip
E E Vokes
U Kim
J M Rosen
Published In
Cancer Res
J Biol Chem
Biochim Biophys Acta
Can Med Assoc J
Proc Soc Exp Biol Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Efference and the conscious perception of movement
Pardew D, Rosen F, Kornhauser D
J Mot Behav . 2013 Aug; 9(2):139-49. PMID: 23947493
Evidence was sought implicating efference in the conscious perception of movement by having subjects (n = 10) scale the time course of an active (efference present) and passive (efference absent)...
2.
The effect of CC14 poisoning on the fate of N methylnicotinamide in the rat
PERLZWEIG W, HUFF J, Rosen F
Fed Proc . 2010 Nov; 5(1 Pt 2):149. PMID: 21066761
No abstract available.
3.
Continuous portable electrocardiography
Rosen F
Can Med Assoc J . 2010 Mar; 98(10):515. PMID: 20329179
No abstract available.
4.
The role of B6-deficiency in the tryptophane-niacin relationships in rats
Rosen F, HUFF J, PERLZWEIG W
J Nutr . 2010 Mar; 33(5):561-7. PMID: 20294351
No abstract available.
5.
The excretion of nicotinic acid derivatives after ingestion of tryptophane by man
PERLZWEIG W, Rosen F
J Biol Chem . 2010 Mar; 167(2):511-4. PMID: 20285046
No abstract available.
6.
On the pellagragenic inactivity of indole-3-acetic acid in the rat
Rosen F, PERLZWEIG W
Arch Biochem . 2010 Mar; 15(1):111-4. PMID: 20266492
No abstract available.
7.
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels
Salama J, Stenson K, Kistner E, Mittal B, Argiris A, Witt M, et al.
Ann Oncol . 2008 Jun; 19(10):1787-94. PMID: 18539617
Background: We hypothesized induction chemotherapy (IndCT) would improve distant control (DC) without compromising locoregional control (LRC) for locoregionally advanced head and neck cancer patients. Additionally, we systematically lowered radiotherapy (RT)...
8.
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience
Brockstein B, Haraf D, Rademaker A, Kies M, Stenson K, Rosen F, et al.
Ann Oncol . 2004 Jul; 15(8):1179-86. PMID: 15277256
Background: Locoregionally advanced, stage IV head and neck cancer has traditionally carried a poor prognosis. We sought to assess changes in patterns of failure, prognostic factors for recurrence, and overall...
9.
Primary immunodeficiency diseases: an update
Chapel H, Geha R, Rosen F
Clin Exp Immunol . 2003 Mar; 132(1):9-15. PMID: 12653830
No abstract available.
10.
Ileal adenocarcinoma in a mild phenotype of abetalipoproteinemia
Al-Shali K, Wang J, Rosen F, Hegele R
Clin Genet . 2003 Mar; 63(2):135-8. PMID: 12630961
Abetalipoproteinemia (ABL) is a rare autosomal recessive disorder that is characterized by defective assembly and secretion of plasma apolipoprotein (apo) B-containing lipoproteins. This disorder results from mutations in the MTP...